Publication | Closed Access

A Randomized, Controlled Trial of Daclizumab vs Anti-thymocyte Globulin Induction for Lung Transplantation

Lung TransplantationAnti-thymocyte Globulin InductionTransplantationControlled TrialHematologyImmunologyPulmonary MedicineImmunotherapyMedicineCell TransplantationLung CancerGraft Rejection